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Conclusions. We suggest that proinflammatory chemoat-Increased renal expression of monocyte chemoattractant pro-
tractants have a role in the development of interstitial inflam-tein-1 and osteopontin in ADPKD in rats.
mation and renal failure in ADPKD.Background. Human autosomal-dominant polycystic kid-
ney disease (ADPKD) is variable in the rate of deterioration
of renal function, with end-stage renal disease (ESRD) oc-
curring in only approximately 50% of affected individuals. Evi- The polycystic kidney diseases (PKDs) are character-dence suggests that interstitial inflammation may be important
ized by the development of fluid-filled, epithelial-linedin the development of ESRD in ADPKD. Han:SPRD rats
cysts derived from renal tubules. PKD can be inheritedmanifest ADPKD that resembles the human disease. Homozy-
gous cystic (Cy/Cy) rats develop rapidly progressive PKD and or acquired. Autosomal-dominant (AD) PKD, the most
die near age 3 weeks. Heterozygous (Cy/) females develop common form seen in humans [1, 2], has a highly variable
slowly progressive PKD without evidence of renal dysfunction onset and renal failure occurs in approximately 50% ofuntil the second year of life, whereas heterozygous (Cy/)
affected individuals [1]. There is growing awareness thatmales develop more aggressive PKD with renal failure begin-
the rate of disease progression is dependent to a signifi-ning by 8 to 12 weeks of age.
Methods. To examine the relationship between proinflam- cant extent upon epigenetic factors that contribute to
matory chemoattractants and the development of interstitial cyst growth, interstitial inflammation and progressive fi-
inflammation and ultimately renal failure in ADPKD, we eval- brosis.uated monocyte chemoattractant protein-1 (MCP-1) and osteo-
In 1989, Kaspareit-Rittinghausen et al described a ro-pontin mRNAs and proteins in kidneys from Han:SRPD rats.
dent model of PKD, the Han:SPRD, which arose sponta-Results. MCP-1 and osteopontin mRNAs, expressed at low
levels in kidneys from normal (/) animals at all ages, were neously in Sprague-Dawley rats [3]. PKD in the Han:
markedly elevated in kidneys from 3-week-old Cy/Cy animals. SPRD rat is inherited as an autosomal dominant trait,
In kidneys from heterozygous (Cy/) adults of either gender, but there is a gene dose effect. Rats of either gender that
MCP-1 and osteopontin mRNAs were more abundant than
inherit two abnormal genes develop rapidly progressivenormal; MCP-1 mRNA was more abundant in Cy/ males
PKD and die with renal failure at approximately threethan in females. Thus, chemoattractant mRNA expression cor-
related with the development of renal failure in Cy/Cy and weeks of age [3, 4]. Heterozygous animals develop slowly
Cy/ rats. Osteopontin mRNA, localized by in situ hybridiza- progressive PKD that resembles in many respects human
tion, was moderately expressed in the renal medulla of normal ADPKD [4, 5]. In heterozygous Han:SPRD rats, the
animals; however, this mRNA was expressed at very high levels gender effect is exaggerated in comparison to the humanin the cystic epithelia of Cy/ and Cy/Cy animals. MCP-1
counterpart. Male heterozygotes develop severe renaland osteopontin proteins, localized by immunohistochemistry,
cystic changes and renal insufficiency soon after sexualwere weakly detected in / kidneys but were densely ex-
pressed in Cy/Cy and in adult Cy/ kidneys, primarily over maturity, and die with renal failure by 12 to 14 months of
cystic epithelium. Increased expression of chemoattractants age [4, 5]. Extensive interstitial inflammation and fibrosis
was associated with the accumulation of ED-1 positive cells develops in conjunction with the onset of renal insuffi-(macrophages) in the interstitium of cystic kidneys.
ciency in male heterozygotes [4, 5]. In contrast, the renal
cysts and interstitial changes progress more slowly in
female heterozygotes [4] and death from renal insuffi-Key words: autosomal-dominant PKD, interstitial inflammation, renal
failure, inherited disease, cysts, fibrosis. ciency does not occur until late in the second year of life
[6]. Interstitial inflammation and fibrosis are thought toReceived for publication January 4, 2001
have important roles in the development and/or progres-and in revised form July 23, 2001
Accepted for publication July 25, 2001 sion of renal dysfunction in a variety of diseases, including
those in which glomeruli are the primary targets [7–9]. 2001 by the International Society of Nephrology
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Monocyte chemoattractant protein-1 (MCP-1) and os- and photographed to assess the relative intensities of the
28S and 18S ribosomal RNA bands and to assure thatteopontin are chemoattractant mediators with specificity
for macrophages. These proteins are expressed at high equal amounts of RNA were loaded in each lane. After
electrophoresis, destaining, and photography, RNA inlevels by tubular epithelial cells in several models of
renal disease associated with pronounced interstitial ab- gels was transferred to Nytran (Schleicher & Schuell) fil-
ters by capillary transfer and fixed to the filters by bakingnormalities [7, 8, 10–17]. To examine the potential rela-
tionship of these proinflammatory factors to the develop- at 80C in vacuo for two hours.
ment of interstitial inflammation and renal failure in
Northern hybridizations and autoradiographyhereditary PKD, we determined the abundance and lo-
calization of MCP-1 and osteopontin mRNAs and pro- For hybridization with osteopontin or MCP-1 DNA
probes, filters were prehybridized at 55C in 3  SETteins and the distribution of macrophages in the kidneys
of Han:SPRD rats. [20 SET is 3 mol/L NaCl, 0.04 mol/L ethylenediamine-
tetraacetic acid (EDTA), 0.6 mol/L Tris-HCl, pH 8), 5%
sodium dodecyl sulfate (SDS), 10  Denhardt’s solu-
METHODS
tion [10Denhardt’s solution is 0.2% Ficoll, 0.2% poly-
Animals vinylpyrrolidone, 0.2% bovine serum albumin (BSA)],
40 mmol/L sodium phosphate buffer, pH 7.8, 100 g/mLHan:SPRD rats were maintained as an inbred colony
in the University of Kansas Medical Center Animal Care sonicated salmon sperm DNA for one hour or longer.
Hybridizations were performed overnight at 55C in 3 Facility as previously described [4]. At selected ages, ani-
mals of each genotype were anesthetized and weighed. SET, 5% SDS, 40 mmol/L sodium phosphate buffer,
pH 7.8, 100 g/mL sonicated salmon sperm DNA, 10%The abdomen was opened, and right kidneys were dis-
sected free of other tissues, removed, weighed, frozen dextran sulfate, with 1 to 3  106 cpm of [32P]-radio-
labeled DNA probe (see below) per mL of hybridizationin dry ice, and stored at 80C (right kidneys were pro-
cessed subsequently for nucleic acid analysis as described solution. Filters were washed at 55C in 1  SSC (20 
SSC is 3 mol/L sodium chloride, 0.3 mol/L trisodium ci-below). Left kidneys were dissected free of other tissues,
removed, weighed, serially sectioned, and fixed by immer- trate, pH 7.0), 0.1% SDS for one hour, 1  SSC, 0.1%
SDS for one hour, and 1  SSC, 0.1% SDS (for MCP-1)sion in 10% buffered formalin. Protocols were reviewed
and approved by the Institutional Animal Care and Use or 0.3  SSC, 0.1% SDS (for osteopontin) for one hour.
Filters were then exposed to Fuji RX film (Fuji, Tokyo,Committee of the University of Kansas Medical Center.
Japan) at 80C.
RNA isolation Renal MCP-1 RNA abundance was assessed by North-
ern analysis from one litter (1 /, 1 Cy/, 1 Cy/Cy,RNA was isolated from right kidneys using a modi-
fication of the technique of Chomczynski and Sacchi both male and female) at two weeks of age, one litter
at three weeks of age (1 /, 1 Cy/, 1 Cy/Cy, both[4, 18]. Briefly, right kidneys were homogenized in GTC
solution (GTC solution is 4 mol/L guanidine thiocyanate, male and female), two litters (2 /, 2 Cy/, both male
and female) at eight weeks of age, and two litters (2/,25 mmol/L trisodium citrate, 0.1 mol/L -mercaptoetha-
nol, 0.1% Antifoam A, pH 7.0) using a polytron tissue 5 Cy/, both male and female) at 24 weeks of age. Renal
osteopontin RNA abundance was assessed by Northernhomogenizer. GTC homogenates were treated by se-
quential addition of 2 N sodium acetate (pH 4), phenol, analysis from two litters (2 /, 2 Cy/, 2 Cy/Cy, both
male and female) at two weeks of age, two litters atand chloroform with vortexing after each addition. After
centrifugation, the aqueous layer was transferred to a three weeks of age (2 /, 2 Cy/, 2 Cy/Cy, both male
and female), two litters (2 /, 2 Cy/, both male andfresh tube, and RNA was precipitated by isopropanol
precipitation. RNA was pelleted by centrifugation, redis- female) at eight weeks of age, and three litters (3 /,
6 Cy/, both male and female) at 24 weeks of age. North-solved, chloroform extracted, and ethanol precipitated.
RNA was again pelleted by centrifugation, redissolved, ern transfers and hybridizations were performed at least
twice with all RNA samples; all results were qualitativelyand quantitated by spectrophotometry. After a final eth-
anol precipitation, RNA was stored at 20C until use. similar. For more accurate comparisons, the most recent
blots were rehybridized with the glyceraldehyde-3-phos-
Gel electrophoresis and Northern blots phate dehydrogenase (GAPDH) probe.
After radiolabeled probes for osteopontin or MCP-1Denaturing agarose gel electrophoresis was performed
as previously described [4] to assess the integrity of RNA had decayed, filters were rehybridized with a 32P-labeled
antisense RNA probe for rat GAPDH. Filters were pre-samples and prior to Northern blotting. Briefly, RNA
samples were denatured in 2.2 mol/L formaldehyde, 50% hybridized at 66C in 3  SET, 0.1% SDS, 10  Den-
hardt’s solution, 250 g/mL for one hour or longer. Hy-formamide and electrophoresed in formaldehyde, agarose
gels. Gels were stained with acridine orange, destained, bridizations were performed overnight at 66C in 3 
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SET, 0.1% SDS, 20 mmol/L sodium phosphate buffer, chelli [20]. For generation of radiolabeled nucleic acid
probes for Northern hybridizations, the insert (“2B7”)pH 7.8, 10Denhardt’s, 250g/mL tRNA, 10% dextran
sulfate, with 106 cpm of [32P]-radiolabeled antisense RNA from this plasmid was isolated and radiolabeled with
-[32P]-cytidine triphosphate (DuPont/NEN, Wilmington,probe (see below) per mL of hybridization solution. Fil-
ters were washed at 66C in 1  SSC, 0.1% SDS for one DE, USA) using a random primed cDNA labeling kit (Pro-
mega, Madison, WI, USA). For generation of radio-hour, 0.3  SSC, 0.1% SDS for one hour, and 0.1 
SSC, 0.1% SDS for one hour. Filters were then exposed labeled RNA probes for in situ hybridizations, the osteo-
pontin plasmid was linearized with Bgl I (for antisenseto Fuji RX film at 80C.
The intensity of autoradiographic signals was quanti- probes) or Mam I (for sense probes) and in vitro transcrip-
tions were performed in the presence of -[35S]-uridinetated using a Macintosh computer, a flat-bed scanner,
and the public domain NIH Image program (developed triphosphate (DuPont/NEN) using T7 (antisense) or T3
(sense) RNA polymerase (Promega); RNA probes wereat the U.S. National Institutes of Health and available on
the Internet at http://rsb.info.nih.gov/nih-image/). Auto- separated from unincorporated precursors using G-50
Quick Spin columns (Boehringer-Mannheim, Mannheim,radiographic signals for osteopontin and MCP-1 were
expressed relative to the GapDH signal. For each filter, Germany).
Plasmid DNA containing MCP-1 cDNA (insert sizevalues were normalized to the 24-week-old male normal
(/) that was arbitrarily assigned a value of 1. 0.66 kb) in pBluescript SK/was obtained from T. Yo-
shimura [21]. The MCP-1 specific portion of this plas-
In situ hybridizations mid was isolated and radiolabeled with -[32P]-cytidine
triphosphate (DuPont/NEN) using a random primedIn situ hybridizations were performed on 10% neutral
buffered formalin-fixed paraffin sections using estab- cDNA labeling kit (Promega).
Plasmid pRcGAP123 containing rat GAPDH cDNAlished protocols [19]. Midcoronal sections were alcohol
dehydrated and incubated with prehybridization solution was obtained from R. Wu [22]. An EcoR I/Xho II frag-
ment of this cDNA encompassing approximately 758containing 1.2 mol/L NaCl, 0.02 mol/L Tris, 0.04% Ficoll,
0.04% BSA, 0.04% polyvinylpyrrolidone, 0.002 mol/L bases of 5 coding sequence was subcloned into pGEM-3Z
(Promega). This plasmid was linearized with EcoR IEDTA, 0.1% salmon sperm DNA, and 0.1 mg/mL yeast
tRNA. Tissue sections were hybridized at 50C over- prior to transcription with SP6 RNA polymerase. Radio-
labeled antisense RNA probes were prepared by in vitronight in an identical solution containing 25% formamide,
10 mmol/L dithiothreitol (DTT), 0.1% SDS, and 4  transcription of linearized plasmid in the presence of
-[32P]-guanosine triphosphate (DuPont/NEN).104 cpm/L 35S-labeled RNA probe (see below). Slides
were washed in 2  SSC for two hours at 60C, and
Immunohistochemistryautoradiograms were generated by exposure to Kodak
Biomax film (Eastman Kodak, Rochester, NY, USA) Immunohistochemistry was performed as previously
described [12, 13, 23]. Briefly, midcoronal sections werefor five days.
After exposure to the BioMax film, slides were dipped obtained from left kidneys, embedded in paraffin, and sec-
tioned at 4 m thickness. Sections were then serially de-in nuclear track silver emulsion (Kodak NTB2) diluted
1:1 with distilled water warmed to 45C in a water bath. paraffinized with xylene. Endogenous peroxidase activity
was quenched with 4:1 methanol:H2O2, and endogenousWhen the emulsion was dry, slides were placed in light-
proof containers and stored at 4C for five days. Slides biotin was blocked with avidin D and biotin blocking
solutions (Vector, Burlingame, CA, USA). Subsequently,were developed, fixed and counterstained with hematox-
ylin. Slides were then viewed on a Nikon microscope sections were incubated in either normal horse or goat
serum (1:20, Vector) for 50 minutes at 25C, followed byequipped with epifluorescence.
As a negative control, prior to incubation in prehybrid- a five-minute rinse in phosphate buffered saline (PBS).
Sections were then incubated for 60 minutes at 25C withization solution sections were incubated in 0.1 mg/mL
RNase in RNAse buffer for 1.5 hours at room tempera- one of the following primary antibodies: (1) MPIIIB10,
a mouse monoclonal IgG antibody to rat osteopontin (di-ture. Slides were then rinsed in RNAse buffer followed
by 2  SSC for two hours. Sections were dehydrated in lution 1:8000; Developmental Studies Hybridoma Bank,
University of Iowa, Iowa City, IA, USA); (2) polyclonalethanol before the addition of the prehybridization solu-
tion and subsequent hybridized as above. As a second rabbit anti-murine MCP-1 (dilution 1:4800; kindly pro-
vided by B. Rollins, Dana-Farber Cancer Institute, Boston,negative control, slides were hybridized with 35S-labeled
sense probe as above. MA, USA); and (3) ED-1, a mouse monoclonal immuno-
globulin G (IgG) antibody that recognizes cytoplasmic
Nucleic acid probe generation antigens in monocytes/macrophages (dilution 1:2000;
Serotec, Oxford, UK). Next, sections were rinsed for fivePlasmid containing rat osteopontin cDNA (insert size
1.1 kb) in pBluescript SK/ was obtained from C. Gia- minutes in PBS and were then incubated with secondary
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antibody [either a biotinylated horse anti-mouse (rat ad-
sorbed) IgG or a biotinylated goat anti-rabbit IgG anti-
body (dilution 1:150; Vector)] for 60 minutes at 25C.
Sections were then incubated in an avidin biotinylated-
horseradish peroxidase complex for 60 minutes at 25C
followed by 0.1 mol/L Tris, pH 7.5, 0.0225% H2O2 for five
minutes. Sections were counterstained with 1% methyl
green solution for 20 minutes. As negative controls, sepa-
rate sections were treated as above with either no primary
antibody or with an irrelevant primary antibody. Sections
of kidneys from rats treated to cause urinary tract obstruc-
tion were used as positive controls for MCP-1, osteopon-
tin, and ED-1 immunostaining.
RESULTS
Whole kidney MCP-1 mRNA levels from homozygous
(Cy/Cy) animals of either gender were elevated at two
and three weeks of age, but were only faintly detected
in normal (/) rats (Fig. 1A). Compared to the expres-
sion of GAPDH, a “housekeeping” RNA, the increases
in MCP-1 were highly selective. Cy/Cy animals died soon
after three weeks of age from renal failure. Renal MCP-1
mRNA levels were also increased in 8- and 24-week-old
heterozygous (Cy/) rats in comparison to/ animals.
MCP-1 mRNA levels, determined in several litters, were
increased in Cy/Cy animals and in Cy/ animals older than
three weeks. Moreover, in adult animals MCP-1 mRNA
levels were increased to a greater extent above/ in male
Cy/ than in female Cy/ animals (Fig. 1B). The mean	
SE increase (Fig. 1) in renal MCP-1:GAPDH ratio for
24-week-old Cy/ rats relative to 24-week-old / males
(used for normalization within the same blot) was 5.6 	
0.5 for Cy/ males and 2.8 	 0.3 for Cy/ females (P 

0.016, Mann-Whitney U test).
Osteopontin mRNA levels was detected in kidneys
from all / animals (Fig. 2A), but were markedly ele-
Fig. 1. (A) Autoradiogram of a Northern blot showing monocyte che-
vated in Cy/Cy kidneys and in 8- and 24-week-old Cy/ moattractant protein-1 (MCP)-1 mRNA levels in kidneys from Han:
SPRD rats of the indicated genotypes, genders, and ages. Also shownanimals of either gender. Osteopontin mRNA levels
are corresponding autoradiograms obtained after blots were rehybrid-tended to be increased to a greater extent in male than ized with a GAPDH probe. Each lane contained 10 g total RNA.
in female Cy/ animals. Additional animals studied at Densitometric ratios of MCP-1 autoradiographic signals to GAPDH
autoradiographic signals were determined as described in the Methods24 weeks of age (Fig. 2B) confirmed higher levels of
section. Values were normalized to the 24-week-old male normal (/)osteopontin mRNA in male than in female Cy/ ani- rat, which was arbitrarily assigned a value of 1. Densitometric ratios
mals. The mean 	 SE increase (Fig. 2) in the renal for male lanes 1 to 10 were: 0.8, 0.9, 3.7, 1.9, 2.0, 4.3, 2.0, 2.8, 1.0 and
3.6. Densitometric values for female lanes 1 to 10 were: 1.1, 1.2, 2.3,osteopontin:GAPDH ratio for 24-week-old Cy/ rats
0.4, 1.5, 4.2, 0.7, 1.9, 2.0, and 2.5. (B) Autoradiogram of a Northernrelative to 24-week-old / males (used for normaliza- blot showing MCP-1 mRNA levels in kidneys from 24-week-old male
tion within the same blot) was 10.6 	 2.3 for Cy/males and female Han:SPRD rats of the indicated genotypes. Also shown are
corresponding autoradiograms obtained after blots were rehybridizedand 6.5 	 0.8 for Cy/ females (P 
 0.076, Mann-Whit-
with a radiolabeled GAPDH probe. Each lane contained 10 g totalney U test). RNA. Densitometric ratios of MCP-1 autoradiographic signals to
In situ hybridization was used to localize the major GAPDH autoradiographic signals were determined as described in
Methods; values were normalized to the male normal (/) rat, whichsites of osteopontin mRNA expression in cystic kidneys.
was arbitrarily assigned a value of 1. Densitometric ratios for male lanesAt three weeks of age, osteopontin mRNA could not 1 to 5 were: 1.0, 6.6, 6.4, 5.5, and 6.1. Densitometric values for female
be detected in renal cortex of normal animals (Figs. 3C), lanes 1 to 5 were: 2.2, 2.4, 2.4, 3.8, and 3.1.
but was strongly expressed in renal medulla (Fig. 3C), as
previously reported [24]. In contrast, osteopontin mRNA
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Fig. 3. Whole kidney autoradiograms of in situ hybridizations for os-
teopontin mRNA in representative sections from Han:SPRD rats. Mag-
nification for all panels is 4. (A) Three-week-old homozygous cystic
(Cy/Cy) rat, antisense riboprobe. (B) Three-week-old male heterozy-
gous (Cy/) rat, antisense riboprobe. Osteopontin was expressed dif-
fusely in the medulla (arrowheads) and focally in the cortex. (C) Three-
week-old male normal (/) rat, antisense riboprobe. Osteopontin
mRNA was diffusely expressed in renal medulla (arrowheads), as pre-
viously reported [24], but was not detected in the cortex. (D) Twenty-
four–week-old male heterozygous (Cy/) rat, sense riboprobe.
Fig. 2. (A) Autoradiogram of a Northern blot showing osteopontin
mRNA levels in kidneys from Han:SPRD rats of the indicated geno-
types, genders, and ages. Also shown are corresponding autoradiograms was intensely expressed in cortex and medulla of Cy/Cy
obtained after blots were rehybridized with a GAPDH probe. Each (Figs. 3A and 4A). Osteopontin mRNA was also focally
lane contained 10 g total RNA. Densitometric ratios of osteopontin
expressed in cystic epithelium from Cy/ animals (Figs.autoradiographic signals to GAPDH autoradiographic signals were de-
termined as described in the Methods section. Values were normalized 3B and 4B), but was not detected to an appreciable
to the 24-week-old male normal (/) rat, which was arbitrarily as- extent in non-cystic parenchyma (Fig. 3B and 4B). Hy-
signed a value of 1. Densitometric ratios for male lanes 1 to 10 were:
bridization with a sense riboprobe was not associated2.2, 8.1, 18.6, 1.8, 4.8, 26.0, 1.1, 24.3, 1.0, and 19.9. Densitometric values
for female lanes 1 to 10 were: 1.2, 4.1, 7.5, 0.8, 2.4, 12.4, 1.0, 17.0, 1.0, with detectable expression in either normal or cystic
and 4.3. (B) Autoradiogram of a Northern blot showing osteopontin kidneys (Figs. 3D and 4C). An examination of MCP-1
mRNA levels in kidneys from 24-week-old male and female Han:SPRD
by in situ hybridization was not done.rats of the indicated genotypes. Also shown are corresponding auto-
radiograms obtained after blots were rehybridized with a radiolabeled Renal MCP-1 was abundant in 3-week-old homozy-
GAPDH probe. Each lane contained 10 g total RNA. Densitometric gous (Cy/Cy) kidneys, primarily in cystic epithelial cells
ratios of osteopontin autoradiographic signals to GAPDH autoradio-
(Fig. 5A), although it was only weakly detected in cysticgraphic signals were determined as described in the Methods section.
Values were normalized to the male normal (/) rat, which was epithelia from 3-week-old Cy/ animals (data not shown).
arbitrarily assigned a value of 1. Densitometric ratios for male lanes 1 Renal MCP-1 was easily detected in the cystic epithelia
to 5 were: 1.0, 8.2, 8.8, 7.9, 8.3. Densitometric values for female lanes
of 24-week-old Cy/ rats (Fig. 5B). MCP-1 could not1 to 5 were: 2.1, 5.9, 7.8, 9.0, 5.5.
be detected in / kidneys by immunohistochemistry
(data not shown).
Osteopontin was abundant in 3-week-old homozygous
(Cy/Cy) kidneys (Fig. 5C), primarily in the cystic epithe-
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Fig. 4. In situ hybridizations for osteopontin
mRNA in representative sections from 3-week-
old male Han:SPRD rats. Bright-field photo-
micrographs of paraffin sections are shown.
All sections were counterstained with Mayer’s
hematoxylin. (A) Section from a homozygous
cystic (Cy/Cy) rat kidney reacted with an
35S-labeled antisense osteopontin riboprobe
(400). Arrowheads denote the intense local-
ization of osteopontin mRNA (green silver
granules) within cystic tubular epithelium. (B)
Heterozygous (Cy/) rat kidney hybridized
with an 35S-labeled antisense osteopontin ribo-
probe (200). Arrowheads denote localiza-
tion of osteopontin mRNA nearly exclusively
within cystic epithelium. Normal renal cortical
parenchyma surrounds cysts. (C ) A cortical
section from a homozygous cystic (Cy/Cy) rat
kidney reacted with the 35S-labeled sense os-
teopontin riboprobe (400) showing only a
faint background staining.
Fig. 5. Immunoperoxidase labeling for MCP-1
(A and B), osteopontin (C and D), and ED-1
(E and F ). All magnifications are 800. (A)
Kidney section from a 3-week-old homozy-
gous cystic (Cy/Cy) rat showing marked im-
munolabeling for MCP-1 within cystic epithe-
lium. (B) Kidney section from a 24-week-old
heterozygous cystic (Cy/) rat showing MCP-1
immunolabeling within cystic epithelium. (C)
Kidney section from a 3-week-old homozy-
gous cystic (Cy/Cy) rat showing diffuse immu-
nolabeling for osteopontin within cystic epi-
thelium. (D) Kidney section from a 24-week-
old heterozygous cystic (Cy/) rat showing
osteopontin immunolabeling within cystic epi-
thelium. (E) Kidney section from a 3-week-
old homozygous cystic (Cy/Cy) rat showing
diffuse interstitial infiltration with ED-1 posi-
tive cells. (F) Kidney section from a 24-week-
old heterozygous cystic (Cy/) rat showing
diffuse interstitial infiltration with ED-1 posi-
tive cells.
lial cells, although it was only weakly detected in cystic osteopontin was localized most intensely within mark-
edly cystic epithelium, while osteopontin expression byepithelia from 3-week-old Cy/ animals (data not shown).
Renal osteopontin was abundantly expressed in the cys- non-dilated, non-cystic tubules was relatively limited. Os-
teopontin was not detected in the renal cortex of 3- andtic epithelia of 24-week-old male Cy/ rats (Fig. 5D)
but not in females (data not shown). In both homozygous 24-week-old / rats (data not shown).
Previous studies have described interstitial infiltratesand heterozygous cystic rats, immunodetectable renal
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in male Cy/ rats [4, 5]. To determine if the cellular growth factors and cytokines [26], and is inhibited by glu-
cocorticoids [27]. MCP-1 expression is increased acuteinfiltrates in Han:SPRD rats included macrophages, we
labeled renal sections with antibodies to ED-1, a macro- renal failure, including that caused by obstruction [12]
or ischemia [10], and in chronic renal failure associatedphage cell surface marker. ED-1 positive cells were
readily detected in the renal interstitium of Cy/ rats with tubulointerstitial nephritis [15, 28].
Osteopontin was originally described as having a role24 weeks of age (Fig. 5F). ED-1 positive cells could be
detected as early as 3 weeks of age in male Cy/ animals. in bone mineralization [29], however it is also expressed
in multiple other tissues, especially those with epithelialKidneys from homozygous cystic (Cy/Cy) animals also
contained significant numbers of ED-1 positive cells components. Similar to MCP-1, osteopontin is a potent
monocyte/macrophage chemoattractant [29]. Osteopon-(Fig. 5E). Normal kidneys had no detectable ED-1 posi-
tive cells (data not shown). tin is induced by several different growth factors and cyto-
kines [29, 30], as well as other mediators [29–34]. Osteo-
pontin, also called uropontin, inhibits calcium oxalate
DISCUSSION
precipitation and has been proposed as an important
Autosomal-dominant polycystic kidney disease is a inhibitor of renal stone formation [35]. Similar to MCP-1,
slowly progressive disorder in humans characterized by osteopontin expression is increased in acute renal failure
the development of progressively enlarging cysts from caused by obstruction [13] or ischemia [14] and in chronic
tubules and the development of renal failure in approxi- renal failure associated with interstitial nephritis [7, 15].
mately 50% of individuals. This disease is associated with The abnormal expression of these proteins in PKD
the appearance in the renal interstitium of inflammatory may be linked to increased tubular epithelial cell prolifer-
cells that may contribute to progressive deterioration of ation or abnormal epithelial cell development that char-
renal function. The Han:SPRD rat is similar to human acterizes renal cyst formation and growth. PKD and
ADPKD, even though defects in different genes cause acute renal failure are both characterized by increased
these conditions. The Han:SPRD rat has proven useful epithelial cell proliferation and less than fully differenti-
for studies of cyst progression, gender dimorphism, and ated tubular epithelial cells as manifest by immature
renal functional deterioration. The primary goal of the histomorphology and fetal patterns of proto-oncogenes
current studies was to examine the expression of MCP-1 and other developmentally regulated genes [4, 36–39].
and osteopontin in relation to the development and pro- In acute renal failure, both epithelial cell dedifferentia-
gressive enlargement of renal cysts and the intrusion of tion and increased MCP-1 and osteopontin expression
renal interstitial inflammation. In heterozygous (Cy/) are transient; however, as shown in the current study, in
animals, the progressive development of cysts was associ- PKD they persist. It has even been suggested that PKD
ated with expression of MCP-1 and osteopontin mRNAs results in part from a defect in normal cellular differenti-
and proteins that was clearly greater in both male and ation [40]. If so, then abnormal expression of MCP-1 and
female Cy/ than in normal littermates. Furthermore, the osteopontin in PKD could be a reflection of abnormal or
increase in these mRNAs in Cy/ kidneys was greater in incomplete epithelial cell differentiation. In preliminary
males than females. In situ hybridization showed that studies there was no elevated expression of MCP-1 or
osteopontin mRNA was expressed in the medullae of osteopontin mRNA in fetal and neonatal kidneys (data
normal animals, but in Cy/ rats it was also prominently not shown); thus, the expression of these chemoattrac-
displayed in focal patches within the cortex, which at tants in PKD is probably not simply a manifestation of
high magnification proved to be cysts lined with epithe- a developmental arrest but more a reflection of the ab-
lial cells containing abundant osteopontin mRNA. Im- normal cystic phenotype.
munohistochemistry indicated that the increased levels Renal histopathologic and functional abnormalities
of MCP-1 and osteopontin mRNAs were accompanied seen in ureteral obstruction are ameliorated by angiotensin-
by increased abundance of the corresponding proteins. converting enzyme (ACE) inhibition, concomitant with
Antibodies to MCP-1 and osteopontin were localized to reductions in chemoattractant production [41]. Analo-
the epithelial cells lining cysts. The current studies are gous improvements in renal histopathology and function
consistent with a previous report of increased MCP-1 are seen in Han:SPRD rats with ACE inhibition [42–44],
mRNA in Han:SPRD rats [25]; in this study, ameliora- but changes in chemoattractants have not been reported.
tion of PKD by altered dietary protein was associated A recent study showed increased MCP-1 and decreased
with less severe interstitial abnormalities and a reduction EGF expression in human obstructive uropathy [45].
in renal MCP-1 mRNA. These findings are analogous to the findings of the cur-
Monocyte chemoattractant protein-1 is induced by rent study and our previous study showing decreased epi-
PDGF in cultured fibroblasts [26] and is also a potent dermal growth factor (EGF) expression in Han: SPRD
chemotactic factor for monocytes/macrophages. It is ex- rats [46]. In the Han:SPRD rat, focal tubular obstruction
has been observed, however most cysts do not show evi-pressed by a variety of cell types, is induced by numerous
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dence of obstruction [47]. Although obstruction of some Whereas interstitial changes may be closely correlated
with the development of renal failure in human andnephrons could possibly lead to increased production of
animal models of PKD, the pathophysiologic pathwaysosteopontin and MCP-1, as seen in ureteral obstruction
leading to the development of interstitial changes remain[12], we found MCP-1 and osteopontin expressed in the
to be defined. Gardner et al demonstrated the presencevast majority of cysts examined, most of which would
of several cytokines in the fluid of patients with ADPKDnot be obstructed. Thus obstruction does not appear an
[53] and also demonstrated a potential role for cytokinesadequate explanation for the expression of these chemo-
in drug induced PKD [54]. In the current study, elevatedattractants in this type of PKD.
expression of chemoattractant mRNA was seen in adultOne clue to the cause of increased production of
Cy/ rats compared to / rats. Additionally, chemo-MCP-1 and osteopontin may lie in their extremely high
attractant mRNA levels were greater in Cy/males thanlevels in Han:SPRD rats with homozygous cystic disease
Cy/ females and thus correlated with the extent of(Cy/Cy). These animals have inherited abnormal genes
interstitial changes and the severity of renal insufficiencyfrom both parents leading to dramatic enlargement of
in Cy/ rats. The presence of ED-1 positive cells inthe kidneys due to cysts. It is reasonable to assume that
the interstitium of kidneys in association with increasedthe homozygous condition impairs epithelial cell func-
abundance of chemoattractants is consistent with thetion to such an extent that compensatory processes that
concept that these proteins may have a role in the devel-seem to hold the Cy/ disease within certain bounds
opment and/or perpetuation of interstitial inflammationare no longer adequate. Thus, it is possible that robust
in progressive PKD. However, it is also possible thatcellular proliferation may be an inciting factor in the
increased production of these proteins is a response toexpression of MCP-1 and osteopontin at such extreme
cyst formation, to some other stimulus, or to cellularlevels. This suggestion is in keeping with observations
stress, and thus these proteins may serve protective roles.that the renal expression of MCP-1 and osteopontin is
A potentially analogous protective role for osteopontinincreased in association with the burst of proliferative
has been suggested by studies in osteopontin knockoutrepair following acute renal injury [10, 14].
mice, in which acute renal failure is more severe than inThe gender difference in Han:SPRD heterozygotes
genetically normal mice [55–57].may provide insight into mechanisms responsible for de-
This study provides evidence to indicate that the in-velopment of renal insufficiency in PKD. Males, which
creased expression of MCP-1 and osteopontin in Cy/develop renal insufficiency in early adulthood, have prom-
rats correlates generally with the progression of renalinent interstitial inflammatory infiltrates and interstitial
dysfunction. It is not clear, however, if MCP-1 and osteo-
fibrosis, whereas females, which maintain normal renal pontin are uniquely responsible for the interstitial changes
function until late in life, have minimal interstitial changes seen in this animal model of hereditary PKD. Osteopon-
[4, 5]. Interstitial abnormalities similar to those seen in tin was present in the renal medullae of normal animals
male Han:SPRD heterozygotes also have been described where inflammation does not appear to be a significant
in human ADPKD [48]. Studies have implicated an impor- factor. In addition, both MCP-1 and osteopontin mRNAs
tant role for tubulointerstitial changes in the development and protein were increased in the kidneys of female
of renal insufficiency in human ADPKD [48, 49], in drug- heterozygous (Cy/) animals that would not be destined
induced animal models of cystic disease [50], and in he- for renal failure until much later than in males, although
reditary animal models of cystic disease [4, 51]. In each the increases were greater in male than female heterozy-
of these instances, renal failure develops in conjunction gotes. Thus, MCP-1 and osteopontin may be only links
with the accumulation of interstitial inflammatory cells in a larger chain of events that results in renal interstitial
and fibrosis. A role for interstitial inflammation and fi- inflammation, interstitial fibrosis, and ultimately func-
brosis in the pathogenesis of renal cystic disease and tional decline in selected individuals with slowly progres-
consequent renal dysfunction is supported by the amelio- sive PKD.
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